Sprint Bioscience: Collaborates to expand its MASH inflammation programme - Redeye
Bildkälla: Stockfoto

Sprint Bioscience: Collaborates to expand its MASH inflammation programme - Redeye

Sprint Bioscience has entered a research collaboration with the Experimental Drug Development Centre (EDDC) in Singapore regarding the therapeutic expansion of Sprint Bioscience’s MASH (metabolic dysfunction-associated steatohepatitis) programme based on STK25 into inflammatory diseases.

Sprint Bioscience has entered a research collaboration with the Experimental Drug Development Centre (EDDC) in Singapore regarding the therapeutic expansion of Sprint Bioscience’s MASH (metabolic dysfunction-associated steatohepatitis) programme based on STK25 into inflammatory diseases.
Börsvärldens nyhetsbrev